IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 174
Titolo Data di pubblicazione Autore(i) File
Exploring small extracellular vesicles for precision medicine in prostate cancer 1-gen-2018 Giulietti, Matteo; Santoni, Matteo; Cimadamore, Alessia; Carrozza, Francesco; Piva, Francesco; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656–61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists 1-gen-2018 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen 1-gen-2018 Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R.
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step? 1-gen-2018 Di Nunno, V.; Santoni, M.; Cimadamore, A.; Battelli, N.; Massari, F.
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications 1-gen-2018 Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A.
Tivozanib for the treatment of renal cell carcinoma 1-gen-2018 Santoni, Matteo; Massari, Francesco; Piva, Francesco; Carrozza, Francesco; Di Nunno, Vincenzo; Cimadamore, Alessia; Martignetti, Angelo; Montironi, Rodolfo; Battelli, Nicola
Prostate cancer grading in 2018: Limitations, implementations, cribriform morphology, and biological markers 1-gen-2018 Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 1-gen-2018 Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M.
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 1-gen-2018 Di Nunno, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Fiorentino, M.; Ciccarese, C.; Iacovelli, R.; Cheng, L.; Lopez-Beltran, A.; Massari, F.; Montironi, R.
Correlation between imaging and pathological findings in isolated prostatic localization of Wegener Granulomatosis 1-gen-2019 Scarcella, S; Dell’Atti, L; Milanese, G; Moroncini, G; Cimadamore, A; Sternardi, F; Giovagnoni, A; Gabrielli, A; Montironi, R; Galosi, Ab.
Prostate cancer pathology: What has changed in the last 5 years 1-gen-2019 Cimadamore, Alessia; Scarpelli, Marina; Raspollini, Maria Rosaria; Doria, Andrea; Galosi, Andrea Benedetto; Massari, Francesco; Di Nunno, Vincenzo; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype 1-gen-2019 Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A.
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 1-gen-2019 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 1-gen-2019 Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY 1-gen-2019 Montesi, L; Palagonia, E; Leone, L; Capretti, C; Cimadamore, A; Dell'Atti, L; Galosi, Ab; Montironi, R
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution 1-gen-2019 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Pisconti, S.; Battelli, N.; Massari, F.
Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer 1-gen-2019 Cimadamore, Alessia; Palagonia, Erika; Piccinni, Paola; Misericordia, Marco; Galosi, Andrea Benedetto; Montironi, Rodolfo
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples 1-gen-2019 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream? 1-gen-2019 Montironi, R.; Cheng, L.; Scarpelli, M.; Cimadamore, A.; Montorsi, F.; Lopez-Beltran, A.
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 1-gen-2019 Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana
Mostrati risultati da 21 a 40 di 174
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile